Skip to main content
Equibles

Lara Smith Weber

CFO

Fractyl Health, Inc. (GUTS)

Equibles does not estimate personal net worth.

Get an email with a short summary when Fractyl Health, Inc. publishes a filing, an earnings call transcript or a press release.

Get GUTS alerts

About Lara Smith Weber

Lara Smith Weber is recorded as CFO at Fractyl Health, Inc. (GUTS). The newest filing on record that lists Lara Smith Weber as CFO at Fractyl Health, Inc. (GUTS) is dated April 24, 2026. Fractyl Health, Inc. reported in an 8-K filed January 6, 2026 that Lara Smith Weber was appointed Chief Financial Officer, effective January 12, 2026. Lara Smith Weber has spoken on 1 earnings call across 1 company, most recently for Fractyl Health, Inc. on May 12, 2026. Fractyl Health, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fractyl Health, Inc. includes Harith Rajagopalan (CEO and Board Member), Sarah Toomey (General Counsel), Christopher Thompson, M.D. (Board Member) and 1 other.

“On December 30, 2025, the Board of Directors (the "Board") of Fractyl Health, Inc. (the "Company") appointed Lara Smith Weber as Chief Financial Officer, effective January 12, 2026 (the "Start Date").”
Fractyl Health, Inc. Form 8-K, filed January 6, 2026 · Read the filing

Lara Smith Weber on recent calls

“Research and development expenses were $15.6 million for Q1-2026, compared to $19.4 million for the same period in 2025.”
CFO, Fractyl Health, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Fractyl Health, Inc.

Recent activity